Stroke:缺血性卒中在非持续性房颤患者中的表型

2015-02-02 李志行译 MedSci原创

动态心脏检测的广泛应用不仅提高了对高风险心律失常,例如持久或阵发性房颤的检测水平,而且还使准确检测其他失常例如室上性心动过速的短暂(<30 秒) 不规则心率成为可能。缺血性卒中的表型可能会帮助我们理解这些非持续性片段在卒中病理生理学上所起到的作用,正如与其相应的持久或阵发的部分。研究方法:在一组连续的卒中患者中,我们回顾性地明确了与非持续性房颤有关的临床和影像学特征(n=126),定义为持续

动态心脏检测的广泛应用不仅提高了对高风险心律失常,例如持久或阵发性房颤的检测水平,而且还使准确检测其他失常例如室上性心动过速的短暂(<30 秒) 不规则心率成为可能。缺血性卒中的表型可能会帮助我们理解这些非持续性片段在卒中病理生理学上所起到的作用,正如与其相应的持久或阵发的部分。

研究方法:


在一组连续的卒中患者中,我们回顾性地明确了与非持续性房颤有关的临床和影像学特征(n=126),定义为持续小于30秒的阵发性心动过速并通过24小时Holter检测伴有不规则的RR间期,进而将研究对象与持续性或阵发性房颤的患者(n=239)以及没有房颤的患者进行比较。



研究结果:

持续性或阵发性房颤患者与非持续性房颤患者之间有显著的不同,其女性患者有更高的患病率 (OR [95% CI], 1.8 [1.1–2.9]),冠心病发病率(1.9 [1.1–3.0])与栓塞影像学特性(2.7 [1.1–6.5])也更加显著,但在吸烟频率(0.4 [0.2–0.8])和高血脂(0.5 [0.3–0.8])方面有较低的水平。与非持续性房颤患者相比,无房颤的患者更加年轻 (0.5 [0.4–0.6] per decade)而且以男性患者(1.7 [1.0–2.8])居多,非持续性房颤的发病率在隐源性和非隐源性卒中患者中是相似的(32% versus 29%)。对于损伤概率地图进行基于Voxel水平的比较发现,在患有或不患有非持续性房颤的隐源性卒中患者之间没有显著的差别。




研究结论:

非持续性房颤患者的临床特点表现出在持续性或阵发性房颤患者和无房颤患者之间存在一种中间表型。除此之外,影像学特征在长期房颤患者中也不完全一样。

原始出处:

Ethem M. Arsava, Demet F. Bas, Enver Atalar, Arzu C. Has, Kader K. Oguz, and Mehmet A. Topcuoglu
Ischemic Stroke Phenotype in Patients With Nonsustained Atrial Fibrillation
Stroke 2015; first published on January 29 2015 as doi:10.1161/STROKEAHA.114.006396

本文是MedSci原创编译整理,欢迎转载!转载请注明来源并附原文链接。谢谢!


版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1806003, encodeId=091b1806003e0, content=<a href='/topic/show?id=b649e9358fa' target=_blank style='color:#2F92EE;'>#缺血性卒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79358, encryptionId=b649e9358fa, topicName=缺血性卒)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=636e2500187, createdName=12498da4m32(暂无昵称), createdTime=Mon Aug 31 00:24:00 CST 2015, time=2015-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1922527, encodeId=4557192252e12, content=<a href='/topic/show?id=3f3156324ff' target=_blank style='color:#2F92EE;'>#持续性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56324, encryptionId=3f3156324ff, topicName=持续性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2c31495, createdName=liuyg0228, createdTime=Thu Aug 20 00:24:00 CST 2015, time=2015-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1892638, encodeId=e129189263876, content=<a href='/topic/show?id=c738e93521f' target=_blank style='color:#2F92EE;'>#缺血性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79352, encryptionId=c738e93521f, topicName=缺血性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66ec123, createdName=guihongzh, createdTime=Sat Feb 14 19:24:00 CST 2015, time=2015-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1535112, encodeId=85781535112f6, content=<a href='/topic/show?id=099f9020145' target=_blank style='color:#2F92EE;'>#表型#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90201, encryptionId=099f9020145, topicName=表型)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b6412593156, createdName=tastas, createdTime=Wed Feb 04 07:24:00 CST 2015, time=2015-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1614257, encodeId=c16c161425e87, content=<a href='/topic/show?id=64f95426122' target=_blank style='color:#2F92EE;'>#房颤患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54261, encryptionId=64f95426122, topicName=房颤患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=937e19519012, createdName=hittouch, createdTime=Wed Feb 04 07:24:00 CST 2015, time=2015-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=14997, encodeId=38291499e40, content=持续性或阵发性房颤患者与非持续性房颤患者之间有显著的不同, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=MedSci客户端网友, createdTime=Tue Feb 03 09:29:00 CST 2015, time=2015-02-03, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1806003, encodeId=091b1806003e0, content=<a href='/topic/show?id=b649e9358fa' target=_blank style='color:#2F92EE;'>#缺血性卒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79358, encryptionId=b649e9358fa, topicName=缺血性卒)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=636e2500187, createdName=12498da4m32(暂无昵称), createdTime=Mon Aug 31 00:24:00 CST 2015, time=2015-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1922527, encodeId=4557192252e12, content=<a href='/topic/show?id=3f3156324ff' target=_blank style='color:#2F92EE;'>#持续性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56324, encryptionId=3f3156324ff, topicName=持续性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2c31495, createdName=liuyg0228, createdTime=Thu Aug 20 00:24:00 CST 2015, time=2015-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1892638, encodeId=e129189263876, content=<a href='/topic/show?id=c738e93521f' target=_blank style='color:#2F92EE;'>#缺血性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79352, encryptionId=c738e93521f, topicName=缺血性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66ec123, createdName=guihongzh, createdTime=Sat Feb 14 19:24:00 CST 2015, time=2015-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1535112, encodeId=85781535112f6, content=<a href='/topic/show?id=099f9020145' target=_blank style='color:#2F92EE;'>#表型#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90201, encryptionId=099f9020145, topicName=表型)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b6412593156, createdName=tastas, createdTime=Wed Feb 04 07:24:00 CST 2015, time=2015-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1614257, encodeId=c16c161425e87, content=<a href='/topic/show?id=64f95426122' target=_blank style='color:#2F92EE;'>#房颤患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54261, encryptionId=64f95426122, topicName=房颤患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=937e19519012, createdName=hittouch, createdTime=Wed Feb 04 07:24:00 CST 2015, time=2015-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=14997, encodeId=38291499e40, content=持续性或阵发性房颤患者与非持续性房颤患者之间有显著的不同, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=MedSci客户端网友, createdTime=Tue Feb 03 09:29:00 CST 2015, time=2015-02-03, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1806003, encodeId=091b1806003e0, content=<a href='/topic/show?id=b649e9358fa' target=_blank style='color:#2F92EE;'>#缺血性卒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79358, encryptionId=b649e9358fa, topicName=缺血性卒)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=636e2500187, createdName=12498da4m32(暂无昵称), createdTime=Mon Aug 31 00:24:00 CST 2015, time=2015-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1922527, encodeId=4557192252e12, content=<a href='/topic/show?id=3f3156324ff' target=_blank style='color:#2F92EE;'>#持续性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56324, encryptionId=3f3156324ff, topicName=持续性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2c31495, createdName=liuyg0228, createdTime=Thu Aug 20 00:24:00 CST 2015, time=2015-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1892638, encodeId=e129189263876, content=<a href='/topic/show?id=c738e93521f' target=_blank style='color:#2F92EE;'>#缺血性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79352, encryptionId=c738e93521f, topicName=缺血性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66ec123, createdName=guihongzh, createdTime=Sat Feb 14 19:24:00 CST 2015, time=2015-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1535112, encodeId=85781535112f6, content=<a href='/topic/show?id=099f9020145' target=_blank style='color:#2F92EE;'>#表型#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90201, encryptionId=099f9020145, topicName=表型)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b6412593156, createdName=tastas, createdTime=Wed Feb 04 07:24:00 CST 2015, time=2015-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1614257, encodeId=c16c161425e87, content=<a href='/topic/show?id=64f95426122' target=_blank style='color:#2F92EE;'>#房颤患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54261, encryptionId=64f95426122, topicName=房颤患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=937e19519012, createdName=hittouch, createdTime=Wed Feb 04 07:24:00 CST 2015, time=2015-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=14997, encodeId=38291499e40, content=持续性或阵发性房颤患者与非持续性房颤患者之间有显著的不同, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=MedSci客户端网友, createdTime=Tue Feb 03 09:29:00 CST 2015, time=2015-02-03, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1806003, encodeId=091b1806003e0, content=<a href='/topic/show?id=b649e9358fa' target=_blank style='color:#2F92EE;'>#缺血性卒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79358, encryptionId=b649e9358fa, topicName=缺血性卒)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=636e2500187, createdName=12498da4m32(暂无昵称), createdTime=Mon Aug 31 00:24:00 CST 2015, time=2015-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1922527, encodeId=4557192252e12, content=<a href='/topic/show?id=3f3156324ff' target=_blank style='color:#2F92EE;'>#持续性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56324, encryptionId=3f3156324ff, topicName=持续性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2c31495, createdName=liuyg0228, createdTime=Thu Aug 20 00:24:00 CST 2015, time=2015-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1892638, encodeId=e129189263876, content=<a href='/topic/show?id=c738e93521f' target=_blank style='color:#2F92EE;'>#缺血性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79352, encryptionId=c738e93521f, topicName=缺血性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66ec123, createdName=guihongzh, createdTime=Sat Feb 14 19:24:00 CST 2015, time=2015-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1535112, encodeId=85781535112f6, content=<a href='/topic/show?id=099f9020145' target=_blank style='color:#2F92EE;'>#表型#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90201, encryptionId=099f9020145, topicName=表型)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b6412593156, createdName=tastas, createdTime=Wed Feb 04 07:24:00 CST 2015, time=2015-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1614257, encodeId=c16c161425e87, content=<a href='/topic/show?id=64f95426122' target=_blank style='color:#2F92EE;'>#房颤患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54261, encryptionId=64f95426122, topicName=房颤患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=937e19519012, createdName=hittouch, createdTime=Wed Feb 04 07:24:00 CST 2015, time=2015-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=14997, encodeId=38291499e40, content=持续性或阵发性房颤患者与非持续性房颤患者之间有显著的不同, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=MedSci客户端网友, createdTime=Tue Feb 03 09:29:00 CST 2015, time=2015-02-03, status=1, ipAttribution=)]
    2015-02-04 tastas
  5. [GetPortalCommentsPageByObjectIdResponse(id=1806003, encodeId=091b1806003e0, content=<a href='/topic/show?id=b649e9358fa' target=_blank style='color:#2F92EE;'>#缺血性卒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79358, encryptionId=b649e9358fa, topicName=缺血性卒)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=636e2500187, createdName=12498da4m32(暂无昵称), createdTime=Mon Aug 31 00:24:00 CST 2015, time=2015-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1922527, encodeId=4557192252e12, content=<a href='/topic/show?id=3f3156324ff' target=_blank style='color:#2F92EE;'>#持续性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56324, encryptionId=3f3156324ff, topicName=持续性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2c31495, createdName=liuyg0228, createdTime=Thu Aug 20 00:24:00 CST 2015, time=2015-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1892638, encodeId=e129189263876, content=<a href='/topic/show?id=c738e93521f' target=_blank style='color:#2F92EE;'>#缺血性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79352, encryptionId=c738e93521f, topicName=缺血性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66ec123, createdName=guihongzh, createdTime=Sat Feb 14 19:24:00 CST 2015, time=2015-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1535112, encodeId=85781535112f6, content=<a href='/topic/show?id=099f9020145' target=_blank style='color:#2F92EE;'>#表型#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90201, encryptionId=099f9020145, topicName=表型)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b6412593156, createdName=tastas, createdTime=Wed Feb 04 07:24:00 CST 2015, time=2015-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1614257, encodeId=c16c161425e87, content=<a href='/topic/show?id=64f95426122' target=_blank style='color:#2F92EE;'>#房颤患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54261, encryptionId=64f95426122, topicName=房颤患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=937e19519012, createdName=hittouch, createdTime=Wed Feb 04 07:24:00 CST 2015, time=2015-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=14997, encodeId=38291499e40, content=持续性或阵发性房颤患者与非持续性房颤患者之间有显著的不同, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=MedSci客户端网友, createdTime=Tue Feb 03 09:29:00 CST 2015, time=2015-02-03, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1806003, encodeId=091b1806003e0, content=<a href='/topic/show?id=b649e9358fa' target=_blank style='color:#2F92EE;'>#缺血性卒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79358, encryptionId=b649e9358fa, topicName=缺血性卒)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=636e2500187, createdName=12498da4m32(暂无昵称), createdTime=Mon Aug 31 00:24:00 CST 2015, time=2015-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1922527, encodeId=4557192252e12, content=<a href='/topic/show?id=3f3156324ff' target=_blank style='color:#2F92EE;'>#持续性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56324, encryptionId=3f3156324ff, topicName=持续性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2c31495, createdName=liuyg0228, createdTime=Thu Aug 20 00:24:00 CST 2015, time=2015-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1892638, encodeId=e129189263876, content=<a href='/topic/show?id=c738e93521f' target=_blank style='color:#2F92EE;'>#缺血性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79352, encryptionId=c738e93521f, topicName=缺血性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66ec123, createdName=guihongzh, createdTime=Sat Feb 14 19:24:00 CST 2015, time=2015-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1535112, encodeId=85781535112f6, content=<a href='/topic/show?id=099f9020145' target=_blank style='color:#2F92EE;'>#表型#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90201, encryptionId=099f9020145, topicName=表型)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b6412593156, createdName=tastas, createdTime=Wed Feb 04 07:24:00 CST 2015, time=2015-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1614257, encodeId=c16c161425e87, content=<a href='/topic/show?id=64f95426122' target=_blank style='color:#2F92EE;'>#房颤患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54261, encryptionId=64f95426122, topicName=房颤患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=937e19519012, createdName=hittouch, createdTime=Wed Feb 04 07:24:00 CST 2015, time=2015-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=14997, encodeId=38291499e40, content=持续性或阵发性房颤患者与非持续性房颤患者之间有显著的不同, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=MedSci客户端网友, createdTime=Tue Feb 03 09:29:00 CST 2015, time=2015-02-03, status=1, ipAttribution=)]
    2015-02-03 MedSci客户端网友

    持续性或阵发性房颤患者与非持续性房颤患者之间有显著的不同

    0

相关资讯

控制房颤心室率的药物知多少

在以往多期的文章中,我们曾详细介绍过房颤的射频消融及抗凝治疗。尽管对于房颤患者最理想的治疗莫过于恢复窦性心律,但对于左房内径过大(一般大于55mm)、合并没有纠正的二尖瓣狭窄及其它器质性心脏病的房颤来说复律成功的比率不高,或者即使复为窦性心律也很难维持,这种情况下可退而其次应用药物减慢较快的心室率以改善症状。今天,小编就带领大家简单了解一下这类药物。 β受体阻滞剂为临床中控制房颤心室率最

研究:肥胖增房颤风险

古人言:腰带长,寿命短,一胖百病缠。肥胖对健康的影响越来越受到人们的关注。那么如何判断肥胖呢?这里推荐一个简单的方法,体重指数法。体重指数(BMI)的计算公式:BMI=体重(Kg)/身高(m)2BMI<25为正常,25≤BMI<30为超重,BMI≥30为肥胖。 有研究表明肥胖与房颤之间存在相关性。该研究共入选的5282例受试者,研究者根据体重指数(BMI)将入选者分为正常体重组、超重组和

房颤患者卒中预防风险CHA2DS2-VASc评分公式

房颤患者卒中预防风险CHA2DS2-VASc评分公式

JACC:房颤卒中风险评估1分的患者口服抗凝药是否具有受益?

目前的指南对于房颤患者的管理,建议基于风险口服抗凝药预防卒中。然而,未使用预防性治疗的房颤相关性卒中风险存在很大差异。高风险患者,在日常管理中不存在差异,因为都服用口服抗凝药治疗;低风险患者,其治疗取决于卒中风险评估。欧洲和美国指南都建议使用CHA2DS2-VASc评分经行分类。CHA2DS2-VASc为1分的低风险患者,欧洲心脏协会建议使用维生素拮抗剂,或者选用效果更好的口服抗凝药。然而,C

JACC:支持用植入设备检测无症状房颤的十点理由

随着起搏器、心脏再同步化治疗,以及植入式心律转复除颤器(ICD)等广泛进入临床,之前未确诊的心律失常特别是房颤,也被越来越多地被发现。那么如何看待这些无症状的被检测出的房颤?美国心脏学院专家会员Aman Chugh提出了以下十点认识。 1.对于伴有隐源性脑卒中的患者,植入式设备的房颤检出率要比传统的监测方式如心电图或动态心电图更高。 2、对于发生脑卒中的患者,30天内事件监测相对应

Stroke:房颤并发心力衰竭患者左心功能不全程度、症状与栓塞风险之间关系

目前在房颤患者中左心室功能障碍(LVSD)、心力衰竭(HF)症状、栓塞风险之间关系方面的数据十分有限。研究方法:HF患者参与氯吡格雷联合厄贝沙坦预防房颤患者血管事件(ACTIVE)试验,但并不随机分配口服抗凝药物,他们被归类为保存射血分数型心衰和减低射血分数型心衰。如果是减低型,LVSD被分为轻度、中度或重度。症状通过纽约心脏病协会分级进行定量。主要结果为中风、短暂性脑缺血发作和全身性栓塞的综合。